1. Home
  2. VTGN vs OMH Comparison

VTGN vs OMH Comparison

Compare VTGN & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.26

Market Cap

25.3M

Sector

Health Care

ML Signal

HOLD

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$0.42

Market Cap

24.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTGN
OMH
Founded
1998
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
25.3M
24.4M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
VTGN
OMH
Price
$0.26
$0.42
Analyst Decision
Hold
Hold
Analyst Count
3
1
Target Price
$0.90
N/A
AVG Volume (30 Days)
4.0M
80.5K
Earning Date
06-16-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$124.49
$28.40
Revenue Next Year
$353.99
$23.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.32
52 Week High
$5.14
$1.91

Technical Indicators

Market Signals
Indicator
VTGN
OMH
Relative Strength Index (RSI) 32.41 33.57
Support Level $0.20 N/A
Resistance Level $0.66 $1.38
Average True Range (ATR) 0.05 0.07
MACD -0.03 -0.01
Stochastic Oscillator 10.27 27.33

Price Performance

Historical Comparison
VTGN
OMH

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: